This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Thalidomide

Authoring team

The drug thalidomide was used during the early 1960s as a sedative during pregnancy. It was withdrawn in 1962 when it was shown that taking the drug during days 30 to 70 of gestation resulted in gross limb deformity - phocomelia. This experience has demonstrated that animal models and tests on adults are insufficient to guarantee the absence of teratogenic effects.

However, one should be circumspect about attributing single cases of deformity to a drug taken during pregnancy.

Of 1000 births there will be:

  • 5 deaths from major malformations
  • 10 babies with clinically significant abnormalities

Only very rarely may these deformities be attributed to drugs taken during the pregnancy.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.